OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+24.94%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$177M
AUM Growth
+$177M
Cap. Flow
-$17.8M
Cap. Flow %
-10.06%
Top 10 Hldgs %
99.72%
Holding
12
New
1
Increased
1
Reduced
3
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$65.3M 36.93% 2,600,410
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
$48.2M 27.27% 1,074,612 -154,900 -13% -$6.95M
FGEN icon
3
FibroGen
FGEN
$47.8M
$16.9M 9.57% 314,348 -313,144 -50% -$16.8M
SNNA
4
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$16.9M 9.55% +758,610 New +$16.9M
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$9.03M 5.11% 579,650
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$6.94M 3.92% 1,204,053 -163,200 -12% -$940K
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$4.45M 2.51% 551,477 +250,000 +83% +$2.02M
EGLT
8
DELISTED
Egalet Corporation
EGLT
$3.7M 2.09% 2,889,926
CDTX icon
9
Cidara Therapeutics
CDTX
$1.66B
$3.6M 2.04% 444,965
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.29M 0.73% 223,457
EPIX icon
11
ESSA Pharma
EPIX
$11.4M
$492K 0.28% 1,696,969
NBRV
12
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-1,139,035 Closed -$11.9M